ImmunityBio (IBRX) Net Margin (2014 - 2026)
ImmunityBio (IBRX) reported Net Margin of 1431.47% for Q1 2026, down 64622.0% year-over-year from N/an in Q1 2025, and down 784.53% on a QoQ basis from 161.83% in Q4 2025.
ImmunityBio (IBRX) has 13 years of Net Margin data on file, last reported at 1431.47% in Q1 2026.
- Quarterly Net Margin fell 64622.0% year-over-year to 1431.47% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 606.22% (up 70444.0% YoY) and the FY2025 annual result came in at 310.25%, up 249508.0% from the prior year.
- Net Margin fell to 1431.47% in Q1 2026 per IBRX's latest filing, from 161.83% in the prior quarter.
- Across five years, Net Margin topped out at 161.83% in Q4 2025 and bottomed at 735700.0% in Q1 2022.
- The 5-year median for Net Margin is 32384.17% (2023), against an average of 132741.68%.
- The widest annual swing landed in 2022, when Net Margin slumped 67780000 bps; it then jumped 70331583 bps in 2023.
- Tracing IBRX's Net Margin over 5 years: stood at 148391.78% in 2022, then decreased by 13 bps to 167923.74% in 2023, then soared by 100 bps to 783.62% in 2024, then soared by 79 bps to 161.83% in 2025, then tumbled by 785 bps to 1431.47% in 2026.
- Per Business Quant, the three latest IBRX Net Margin figures stand at 1431.47% (Q1 2026), 161.83% (Q4 2025), and 209.83% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.65% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -1,431.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,431.47% |
| Dec 31, 2025 | -161.83% |
| Sep 30, 2025 | -209.83% |
| Jun 30, 2025 | -350.44% |
| Mar 31, 2025 | -785.25% |
| Dec 31, 2024 | -783.62% |
| Sep 30, 2024 | -1,404.39% |
| Jun 30, 2024 | -12,854.25% |
| Mar 31, 2024 | -335,325.00% |
| Dec 31, 2023 | -167,923.74% |
| Sep 30, 2023 | -116,636.59% |
| Jun 30, 2023 | -337,104.88% |
| Mar 31, 2023 | -32,384.17% |
| Dec 31, 2022 | -148,391.78% |
| Sep 30, 2022 | -94,204.24% |
| Jun 30, 2022 | -270,957.14% |
| Mar 31, 2022 | -735,700.00% |
| Dec 31, 2021 | -23,475.13% |
| Sep 30, 2021 | -133,983.33% |
| Jun 30, 2021 | -26,367.26% |
| Mar 31, 2021 | -57,900.00% |
| Dec 31, 2020 | -326,538.10% |
| Sep 30, 2020 | -43,821.19% |
| Jun 30, 2020 | -11,930.50% |
| Mar 31, 2020 | -22,683.03% |
| Dec 31, 2019 | -1,222,333.33% |
| Sep 30, 2019 | -129,841.67% |
| Jun 30, 2019 | -98,129.41% |
| Mar 31, 2019 | -357,700.00% |
| Dec 31, 2018 | 1,093,957.14% |
| Sep 30, 2018 | -76,241.94% |
| Jun 30, 2018 | -693,300.00% |
| Mar 31, 2018 | -550,380.00% |
| Dec 31, 2017 | -204,058.33% |
| Sep 30, 2017 | -299,612.50% |
| Jun 30, 2017 | -167,514.29% |
| Mar 31, 2017 | -222,863.64% |
| Dec 31, 2016 | -173,128.57% |
| Sep 30, 2016 | -265,808.33% |
| Jun 30, 2016 | -283,308.33% |
| Mar 31, 2016 | -511,283.33% |
| Dec 31, 2015 | 1,390,840.00% |
| Sep 30, 2015 | -463,120.00% |
| Jun 30, 2015 | -143,838.46% |
| Mar 31, 2015 | -27,374.17% |
| Dec 31, 2014 | -2,790.82% |
| Sep 30, 2014 | -673.68% |
| Jun 30, 2014 | -1,125.81% |
| Mar 31, 2014 | -288.81% |